Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-05 Lewis Tanya EVP, Chief Reg. Affairs Exercise or conversion +5,650 6,189
2021-02-05 Lewis Tanya EVP, Chief Reg. Affairs Exercise or conversion · Restricted Stock Units −5,650 16,950
2021-02-05 Frenkel Ran EVP, Chief Dev. Officer Exercise or conversion +5,650 41,384
2021-02-05 Frenkel Ran EVP, Chief Dev. Officer Exercise or conversion · Restricted Stock Units −5,650 16,950
2021-02-05 Mason Michael SVP, CFO & Treasurer Exercise or conversion +8,150 8,150
2021-02-05 Mason Michael SVP, CFO & Treasurer Exercise or conversion · Restricted Stock Units −8,150 24,450
2021-02-05 Shacham Sharon President & CSO Exercise or conversion +14,300 770,789
2021-02-05 Shacham Sharon President & CSO Exercise or conversion +14,300 569,422
2021-02-05 Shacham Sharon President & CSO Exercise or conversion · Restricted Stock Units −14,300 42,900
2021-02-05 Shacham Sharon President & CSO Exercise or conversion · Restricted Stock Units −14,300 42,900
2021-02-05 Kauffman Michael Chief Executive Officer Exercise or conversion +14,300 569,422
2021-02-05 Kauffman Michael Chief Executive Officer Exercise or conversion +14,300 770,789
2021-02-05 Kauffman Michael Chief Executive Officer Exercise or conversion · Restricted Stock Units −14,300 42,900
2021-02-05 Kauffman Michael Chief Executive Officer Exercise or conversion · Restricted Stock Units −14,300 42,900
2020-12-18 Mirza Mansoor Raza Director Exercise or conversion +5,000 $5.43 $27K 5,000
2020-12-18 Mirza Mansoor Raza Director Sale −5,000 $18.00 $90K 0
2020-12-18 Mirza Mansoor Raza Director Exercise or conversion · Stock Option (right to buy) −5,000 0
2020-12-07 Mirza Mansoor Raza Director Exercise or conversion +20,000 $5.43 $109K 20,000
2020-12-07 Mirza Mansoor Raza Director Sale −5,000 $16.05 $80K 15,000
2020-12-07 Mirza Mansoor Raza Director Sale −5,000 $16.05 $80K 10,000

Page 19 of 29 · 570 trades